Commercial models
Engagement models for formulation manufacturers, capsule filling plants and distributors.
India
Finished-dosage manufacturers, capsule formulators and secondary pellet processors across India’s pharmaceutical clusters.
From neutral sugar spheres made on the dedicated first floor to gastro-resistant enteric pellets, domestic supply is built around short transit and batch consistency.
Export
An active Import Export Code and proximity to Hyderabad airport and dry-port terminals support overseas buyers, with export-grade packaging.
International work is qualified against the destination regulatory dossier, product registration and climatic-zone stability, including Zone IV A and Zone IV B.
Workflow
01
Received through the technical portal, direct business-development contact, or a referral.
02
Corporate identity, destination country and drug application are verified.
03
Drug load (% w/w), pharmacopoeia (IP/USP/BP) and volume are confirmed.
04
Documentation needs, monograph alignment and test parameters are reviewed.
05
Technical samples and a certificate of analysis are sent for laboratory fill trials.
06
Pricing, delivery, release terms and Incoterms.
07
Specifications are approved, supply terms are executed, and a purchase order is issued.
08
The batch is staged in a 200 kg, 300 kg or 500 kg fluid bed suite.
09
Assay by HPLC, dissolution on eight bowls, moisture by Karl Fischer, and particle size.
10
Batch manufacturing record audit, certificate of analysis and formal release.
11
Double heat-sealed polyethylene liners with desiccant, inside tamper-evident HDPE containers.
12
Climate-controlled domestic transport, or export staging with the dossier packet.
Specifications, lead times and confidential sample protocols, with the business development team.
